

Cover Story
COVID-19 & CancerFreeGuest Editorial
As the crisis triggered by the COVID-19 pandemic deepens, the two separate, unequal societies that make up the United States of America are equally frightened, bewildered, and unsure of what comes next.
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- How George Tidmarsh crossed the FDA-industry Rubicon
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA




















